European Journal of Neurology

Calendar
pp. i-i(1)

Instructions for Authors
pp. ii-iii(2)

Delayed recovery of conjugate eye deviation and head version
pp. e1-e3(3)
Authors: Togay-Işikay, C.; Bolluk, B.; Ergin, Ö.; Akbostancı, M.C.

PANDAS in siblings: a common risk?
pp. e4-e4(1)
Authors: Dranitzki, Z.; Steiner, I.

MRI scans of cervical cord provide evidence of anterior horn lesion in a patient with tick-borne encephalomyeloradiculitis
pp. e5-e6(2)
Authors: Stich, O.; Reinhard, M.; Rauer, S.

Comments on the report of the EFNS task force on IFN-beta antibodies in multiple sclerosis
pp. e7-e7(1)
Author: Freedman, M. S.

Guidelines on use of anti-IFN-B antibody measurements in multiple sclerosis: report of an EFNS Task Force on IFN-B antibodies in multiple sclerosis
pp. e8-e9(2)
Authors: Burks, J. S.; Noronha, A.

Reply to Freedman and Burks
pp. e10-e11(2)
Authors: Sørensen, P. S.

Relapsing neuromyelitis optica responsive to glatiramer acetate treatment
pp. e12-e13(2)
Authors: Gartzen, K; Limmroth, V; Putzki, N

Letter to the Editor - Comments on published article by F. Deisenhammer et al.
pp. e14-e14(1)
Authors: Sobek, O.; Adam, P.; Svatonova, J.

Reply to Sobek and colleagues
pp. e15-e15(1)
Author: Deisenhammer, F.

16q-linked autosomal dominant cerebellar ataxia in a Korean family
pp. e16-e17(2)
Authors: Lee, P. H.; Park, H. Y.; Jeong, S.-Y.; Hong, J.-H.; Kim, H. J.

Acute stroke units are effective, also in eastern Europe
pp. 595-596(2)
Authors: Brainin, M.; Tatschl, C.

Resource allocation to brain research in Europe
pp. 597-597(1)
Authors: Sørensen, Per Soelberg

Remission of progressive multifocal leukoencephalopathy and primary central nervous system lymphoma in an HIV-infected patient
pp. 598-602(5)
Authors: Lima, M. A.; Katz-Brull, R.; Lenkinski, R. E.; Nunez, R.; Feinrider, D.; Koralnik, I. J.

Hospital-referred polyneuropathies-causes, prevalences, clinical- and neurophysiological findings
pp. 603-608(6)
Authors: Rudolph, T.; Farbu, E.

Prevalence and cognitive performances of vascular cognitive impairment no dementia in Japan: the Osaki-Tajiri Project
pp. 609-616(8)
Authors: Ishii, H.; Meguro, K.; Yamaguchi, S.; Ishikawa, H.; Yamadori, A.

Myasthenia gravis patients with ryanodine receptor antibodies have distinctive clinical features
pp. 617-620(4)
Authors: Romi, F.; Aarli, J. A.; Gilhus, N. E.

Polymorphisms at codons 129 and 219 of the prion protein gene (PRNP) are not associated with sporadic Alzheimer's disease in the Korean population
pp. 621-626(6)
Authors: Jeong, B.-H.; Lee, K.-H.; Jeong, Y.-E.; Hwang, K.-A.; Lee, Y.-J.; Carp, R. I.; Ju, Y.-R.; Kim, Y.-S.

Reduction of optic nerve fiber layer thickness in CADASIL
pp. 627-631(5)
Authors: Parisi, V.; Pierelli, F.; Coppola, G.; Restuccia, R.; Ferrazzoli, D.; Scassa, C.; Bianco, F.; Parisi, L.; Fattapposta, F.

Action and object naming in Parkinson's disease without dementia
pp. 632-637(6)
Authors: Cotelli, M.; Borroni, B.; Manenti, R.; Zanetti, M.; Arévalo, A.; Cappa, S. F.; Padovani, A.

A comparative study of chronic inflammatory demyelinating polyradiculoneuropathy with and without diabetes mellitus
pp. 638-643(6)
Authors: Kalita, J.; Misra, U. K.; Yadav, R. K.

Awareness of potential valvulopathy risk with pergolide and changes in clinical practice after label change: a survey among European neurologists
pp. 644-649(6)
Authors: LLedó, A.; Dellva, M. A.; Strombom, I. M.; Wilkie, J. L.; Jungemann, Mark E.; Royer, M. G.; Simmons, V. E.; Cavazzoni, P. A.

Antigen-specific oligoclonal bands in cerebrospinal fluid and serum from patients with anti-amphiphysin- and anti-CV2/CRMP5 associated paraneoplastic neurological syndromes
pp. 650-653(4)
Authors: Stich, O.; Rauer, S.

Paresthesia as a favorable predictor of migraine prophylaxis using topiramate
pp. 654-658(5)
Authors: Lee, S.-T.; Chu, K.; Park, J.-E.; Park, H.-J.; Park, J.-H.; Lee, S.-H.; Kim, M.

Clinical characteristics of carriers of a GAG deletion in the DYT1 gene amongst Polish patients with primary dystonia
pp. 659-662(4)
Authors: Szczaluba, K.; Jurek, M.; Milewski, M.; Friedman, A.; Kadziolka, B.; Szolna, A.; Bal, J.; Mazurczak, T.

Double-blind crossover trial of gabapentin in SPG4-linked hereditary spastic paraplegia
pp. 663-666(4)
Authors: Scheuer, K. H.; Svenstrup, K.; Jennum, P.; á Rogvi-Hansen, B.; Werdelin, L.; Fenger, K.; Nielsen, J. E.

Resource allocation to brain research in Denmark: an example for other European countries
pp. 667-671(5)
Authors: Olesen, J.; Lekander, I.; Sobocki, P

Timing of stenting of symptomatic carotid stenosis is predictive of 30-day outcome
pp. 672-678(7)
Authors: Topakian, R.; Strasak, A. M.; Sonnberger, M.; Haring, H.-P.; Nussbaumer, K.; Trenkler, J.; Aichner, F. T.

What is the relationship among atherosclerosis markers, apolipoprotein E polymorphism and dementia?
pp. 679-682(4)
Authors: Altamura, C.; Squitti, R.; Pasqualetti, P.; Tibuzzi, F.; Silvestrini, M.; Ventriglia, M. C.; Cassetta, E.; Rossini, P. M.; Vernieri, F.

Cardioembolic stroke secondary to non-bacterial endocarditis in wegener disease
pp. 683-685(3)
Authors: Caballero, P. E. Jiménez; Martín, T. Segura

Cladribine in aggressive forms of multiple sclerosis
pp. 686-689(4)
Authors: Martinez-Rodriguez, J. E.; Cadavid, D.; Wolansky, L. J.; Pliner, L.; Cook, S. D.

Imaging of acetylcholine esterase activity in brainstem nuclei involved in regulation of sleep and wakefulness
pp. 690-693(4)
Authors: Eggers, C.; Szelies, B.; Bauer, B.; Wienhard, K.; Schröder, H.; Herholz, K.; Heiss, W.-D.

The use of gabapentin in chronic cluster headache patients refractory to first-line therapy
pp. 694-696(3)
Authors: Schuh-Hofer, S.; Israel, H.; Neeb, L.; Reuter, U.; Arnold, G.

Anterior opercular syndrome in frontotemporal lobar degeneration with ubiquitin-only immunoreactive neuronal changes
pp. 697-700(4)
Authors: Rektorova, I.; Matej, R.

Efficacy of lisinopril in migraine prophylaxis - an open label study
pp. 701-703(3)
Authors: Schuh-Hofer, S.; Flach, U.; Meisel, A.; Israel, H.; Reuter, U.; Arnold, G.

Carotidynia: a new case for an old controversy
pp. 704-705(2)
Authors: Tardy, J.; Pariente, J.; Nasr, N.; Peiffer, S.; Dumas, H.; Cognard, C.; Larrue, V.; Chollet, F.; Albucher, J.-F.

Association study of a functional variant in intron 8 of the dopamine transporter gene and migraine susceptibility
pp. 706-707(2)
Authors: McCallum, L. K.; Fernandez, F.; Quinlan, S.; Macartney, D. P.; Lea, R. A.; Griffiths, L. R.

Brain research has high returns but Europe is lagging behind
pp. 708-710(3)
Authors: Sobocki, P.; Olesen, J.; Jönsson, B.

Erratum
pp. 711-711(1)